Phenytoin is used as both an abortive and preventive medication in seizure management.
The total phenytoin reference range varies by age, as follows:
Toxic phenytoin levels are defined as greater than 30 µg/mL.
Lethal levels are defined as greater than 100 µg/mL.
The reference range of free phenytoin is 1-2.5 µg/mL.
In patients with renal failure associated with
hypoalbuminemia, free phenytoin levels may be more accurate than total phenytoin levels.However, the Sheiner-Tozer formula (below) can be used to correct the phenytoin level.
Adjusted concentration = measured total concentration / [(0.2 x albumin) + 0.1].
Administration of phenytoin and interpretation of serum phenytoin levels vary depending on the clinical scenario. Loading doses to achieve rapid therapeutic levels should be checked 1 hour after an intravenous loading dose and 24 hours after an oral loading dose.
Patients who are on long-term phenytoin therapy generally do not need to be monitored at intervals less than 3-12 months after a steady state has been reached unless clinically indicated, for example in patients who may have intentionally or unintentionally taken a toxic dose.
Although the reference range is between 10 and 20 µg/mL, about half of patients’ seizures are controlled at values lower and higher than the therapeutic range.
Some adverse effects of phenytoin are related to specific serum levels.
Nystagmus is frequently observed at levels greater than 20 µg/mL.At greater than 30 µg/mL, patients may exhibit slurring of speech, ataxia, and movement disorders such as tremor, choreoathetosis, and orofacial dyskinesia.At serum levels that exceed 40 µg/mL, patients are often lethargic, stuporous, and confused and may require aggressive supportive measures.